Larson Yi
EVP & Chief Financial Officer at Turning Point Therapeutics, Inc.
- Sold, on record
- $3.8M
- Dollars the filings state
- Form 4 sales
- 1
- Latest Feb 2, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Turning Point Therapeutics, Inc.EVP & Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Turning Point Therapeutics, Inc.UnusualFeb 2 2021
Sold 30,000 shares at $126.73 ($3.8M)
Larson Yi, EVP & Chief Financial Officer
Sold 91.7% of holdings ($4.1M position)2,704 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (1)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2021 | Turning Point Therapeutics, Inc. | EVP & Chief Financial Officer | Form 4 sale | 30,000 | $3.8M | 91.7% | Unusual | SEC |